Pharmaceutical compositions comprising NEP-inhibitors, inhibitors of the endogenous endothelin producing system and HMG CoA reductase inhibitors
Details for Australian Patent Application No. 2005315608 (hide)
International Classifications
Event Publications
12 July 2007 PCT application entered the National Phase
PCT publication WO2006/064016 Priority application(s): WO2006/064016
31 March 2011 Application Accepted
Published as AU-B-2005315608
28 July 2011 Standard Patent Sealed
12 July 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired
This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2005315607-Diphenylurea derivatives useful as potassium channel activators
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
![](/images/main/3dbox_small.png)
- Editable Word format reports
- For IP Professionals
- Multiuser